Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
King musta said something right for once.
That Assumes no value for neuvax. This stock is still 90% based on neuvax.
Guess Im drinking bud I've this weekend
Gonna be an interesting ride, quite interested in gene therapy and blue has top notch management.
It's run on insider purchases twice now in the past 2 months. Wonder if it'll stay up this time.
No problem
Roche commercializes herceptin not pfizer
Volatile stocks with alot of interest seem to move more on non news than news. Look at AFFY, it always goes up on zero news. Its all part of the game here, most people bash CLSN on twitter as the big boys buy 100k shares. Buy on dips and be patient this has a few years to go before they submit to the fda
Because when one person writes 10 articles about a single stock in a month, no one cares anymore.
Haha same here, keeps me occupied at work when im bored (almost all day)
Estimating a close around .335 but im long anyway so these daily ups and downs are somewhat irrelevant.
Im in right around 5 but I do foresee this doubling within 6-12 months. Even at $150 mln market cap this is a bit undervalued once more is in the pipeline
Someone bought 150k shares today..
My concern is mainly with the filings that show no real financial benefit from ZAO's revenues. I want to know how tjey are connected and currently why they woild be worth more than a penny.
Been monitoring the posts but not as active since I sold 2 weeks ago. Still interested but not sure what to really believe yet.
Yea I probably shouldn't have sold. Eh, live and learn..
I agree but I think some people bought in on expected trial results. Either way im long since November.
China has more HCC cases than here. Also why would they R/S when they are well above $1
I actually agree. I believe that the small amount of data won't have a huge effect on pps. I think it'll be a slow rise once people get in.
Got 1k at 1.76 today. Hopefully we can get back to $2 quickly.
The trial obviously hasn't failed if they are hosting their own symposium. Now we will need to see how good preliminary results are..
Someone may know something with the 290k buy at the bell at a premium.
Yeesh what a crappy day now.
It depends on who is doing the statistical analysis. If its a CRO (likely) they probably don't have an exact deadline.
Haha this man is a joke. Pumping 1 week and calling it to drop another.
The products look like they have potential and Tidmarsch has experience getting companies bought out, but the corporate greed here is ridiculous
Thats why a buyout will never occur and the market cap is a sham. Also why every event that should raise PPS doesn't
Good thing I put the stop on at $150 today.
Ayer capital had 4 million shares at quite a low price. Could be them or someone else, many biotechs tank before a huge run up though
Probably bought at 29 or 30 and is sour it has dropped.
I'd like 1 tangible piece of evidence against this right now. You bash with no reason or rationale.
For 60k, I will do IR exclusively for Rafarma. I'm sure I could do quite a bit better.
I said it won't move much before the catalyst. It always moves after and will either go up significantly or drop like a stone.
I don't expect much of a run up as this stock rarely has run ups before catalysts. Its an OTC so I don't expect much publicity and most run ups occur less than a week in advance of the anticipated trial results. We are still about 1 month away and the results are mainly topline anyway. Enough cash for a year here and im holding at a profit anyway. Science prevails in the long term.
Don't buy then. Im not too worried...
Hit $2 stop losses. Im averaged at $2 and may double at $1.75
0 revenue again and this so called "value" which no one has seen.
I agree, countless hours lost researching what may not even be tied legitimately to the Russian concern. I bought in at .12 and sold at .24 a week ago, but the position was tiny towards what I'm in the hole on right now.
Unfortunately I wasn't in then. Still holding a nice gain but nowhere near that low.
Im only holding shares, no options. One day I will trade options, but not until I do alot more research (im a science guy)